H.R. 919
119th Congress
Chronic Disease Flexible Coverage Act
2
Cosponsors
10
Actions
0
Amendments
2
Committees
—
Since introduced
Received in the Senate and Read twice and referred to the Committee on Finance.
5 March 2025·1 year ago
Summary
Introduced in House · Updated 7 March 2025
Chronic Disease Flexible Coverage Act
This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.
Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.
The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include
- angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
- anti-resorptive therapy for individuals with osteoporosis or osteopenia;
- beta-blockers for individuals with congestive heart failure or coronary artery disease;
- blood pressure monitors for individuals with hypertension;
- inhaled corticosteroids and peak flow meters for individuals with asthma;
- insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
- international normalized ratio testing for individuals with liver disease or bleeding disorders;
- low-density lipoprotein testing for individuals with heart disease;
- statins for individuals with heart disease or diabetes; and
- selective serotonin reuptake inhibitors for individuals with depression.
The bill provides statutory authority for the IRS's guidance.
Timeline
10 actions
Received in the Senate and Read twice and referred to the Committee on Finance.
5 March 2025 · IntroReferral
DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
4 March 2025 · Floor
Considered under suspension of the rules. (consideration: CR H964-966)
4 March 2025 · Floor
Mr. Smith (MO) moved to suspend the rules and pass the bill.
4 March 2025 · Floor
Motion to reconsider laid on the table Agreed to without objection.
4 March 2025 · Floor
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
4 March 2025 · Floor
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
4 March 2025 · Floor
Referred to the House Committee on Ways and Means.
4 February 2025 · IntroReferral
Introduced in House
4 February 2025 · IntroReferral
Introduced in House
4 February 2025 · IntroReferral
Sponsorship
2 cosponsors
Sponsor
Republican:Rep. Buchanan, Vern [R-FL-16]FLCosponsors
- Democrat150%
- Republican150%
- Republican:Rep. Tenney, Claudia [R-NY-24]NY
- Democrat:Rep. Panetta, Jimmy [D-CA-19]CA
Classification
Policy area
TaxationLegislative subjects
Committees
2
Ways and Means Committee
House · Standing
- Referred To4 Feb 2025
Finance Committee
Senate · Standing
- Referred To5 Mar 2025
Cosponsor momentum
Cumulative over time
Cosponsors grew from 1 on 4 February 2025 to 2 on 3 March 2025.
Track Chronic Disease Flexible Coverage Act as it moves through Congress
Get alerts on votes, amendments, and stock-market impact